Mantra and Values
Who We Are
How We Work
Message from the Founders
Get in touch
get in touch
sign up to read
Please verify your email by clicking on the link we have sent to your email address.
Something went wrong while sending you the email. Would you like to retry again?
MLD is a rare, genetic, degenerative, neurometabolic disorder that affects 1 in 40,000 people worldwide.
There are up to 70 different mutations in the GAA gene that cause the symptoms of Pompe disease.
CRISPR Gene Editing to Treat Rare Diseases
A new wave of treatments based on gene editing technology are expected to be made available over the next few years.
Distal Muscular Dystrophy
Distal muscular dystrophy is a general term for a group of rare progressive genetic disorders.
The Evolving Market Access (MA) Landscape in the GCC Region
What are the changes pharmaceutical companies need to be aware of and how to manage them?
The case for Rare Disease Clinical Trials in the Middle East
The objective of this paper is to address clinical trials inclusion in the Middle East.
2023 GENPHARM - All rights reserved